Skip to content

ABT

Abbott Laboratories

Cash flow statement

Cash flow statement
Line, in USDLast 12 months2025202420232022202120202019201820172016201520142013201220112010200920082007
Operating cash flow8.9B9.6B8.6B7.3B9.6B10.5B7.9B6.1B6.3B5.6B3.2B3.0B3.7B3.3B9.3B9.0B8.7B7.3B7.0B5.2B
2.10B2.17B2.21B2.20B1.78B1.89B2.18B1.64B1.39B1.14B1.12B1.11B1.08B1.15B1.80B1.49B1.02B1.09B1.29B1.66B
Free cash flow6.76B7.40B6.35B5.06B7.80B8.65B5.72B4.50B4.91B4.44B2.08B1.86B2.60B2.18B7.52B7.48B7.72B6.19B5.71B3.53B
Depreciation and amortization3.91B3.12B3.22B3.24B3.27B3.54B3.33B3.01B3.28B3.02B1.35B1.47B1.55B1.72B2.78B3.04B2.62B2.09B1.84B1.85B
Stock-based compensation735M664M673M644M685M640M546M519M477M406M310M292M246M262M433M383M387M366M347M430M
Buybacks1.54B0.89B1.30B1.23B3.80B2.30B0.40B0.72B0.24B0.12B0.52B2.24B2.20B1.61B2.36B77M0.87B0.83B1.08B1.06B
Dividends paid4.32B4.12B3.84B3.56B3.31B3.20B2.56B2.27B1.97B1.85B1.54B1.44B1.34B0.88B3.18B2.94B2.67B2.41B2.17B1.96B
Dividends per share2.522.402.242.081.92——————————1.921.761.60——
Free cash flow margin14.0%16.7%15.1%12.6%17.9%20.1%16.5%14.1%16.0%16.2%10.0%9.1%12.8%11.1%39.5%34.9%22.0%20.1%19.3%13.6%